Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22
In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections wer...
Gespeichert in:
| Veröffentlicht in: | Euro surveillance : bulletin européen sur les maladies transmissibles 2022-04, Vol.27 (15), p.1 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 15 |
| container_start_page | 1 |
| container_title | Euro surveillance : bulletin européen sur les maladies transmissibles |
| container_volume | 27 |
| creator | Melidou, Angeliki Ködmön, Csaba Nahapetyan, Karen Kraus, Annette Alm, Erik Adlhoch, Cornelia Mooks, Piers Dave, Nishi Carvalho, Carlos Meslé, Margaux Mi Daniels, Rodney Pebody, Richard |
| description | In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections were confirmed. Substantial proportions of characterised circulating virus subtypes or lineages differed antigenically from their respective northern hemisphere vaccine components. Appropriate levels of influenza virus characterisations should be maintained until the season end and in future seasons, when surveillance is adapted to integrate SARS-CoV-2. |
| doi_str_mv | 10.2807/1560-7917.ES.2022.27.15.2200255 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9012087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2651693603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3845-8f16b8b390a51da31d74ace0fe26990aa155eae8fb0f19cffc4f12a22af8644e3</originalsourceid><addsrcrecordid>eNpdkVFL3TAUx8vYmM7tK4zAHubAW5OTJm1fNuRy5xVEYW7sMZy2J1ppk2vSOtynX4vXi_MlCSe__DknvyT5LHgKBc-PhdJ8kZciT1dXKXCAFPJUqBSAc1DqVbK_I14_O-8l72K85TyTvIS3yZ5UGWips_2kP3O2G8n9RRZoGIOL7E873DBkkTB6xxrftw4Halj1wOoOG2JymQKKalpSYCeHa3kBX9h9G8ZI8Yj9Xl-y1Rj8htCxH3TdenfEplbFMcD75I3FLtKH7X6Q_Pq--rlcL84vT8-WJ-eLWhaZWhRW6KqoZMlRiQalaPIMa-KWQJdTEYVShFTYiltR1tbWmRWAAGgLnWUkD5Kvj7mbseqpqckNATuzCW2P4cF4bM3_N669Mdf-3pRcAC_yKeBwGxD83UhxMH0ba-o6dOTHaEAroUupuZzQTy_QWz_94zTeTElVgNLFRH17pOrgYwxkd80Ibma1ZpZlZllmdWVmtQbmotmqnRI-Pp9p9_7JpfwHBCmdmQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2653582568</pqid></control><display><type>article</type><title>Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Melidou, Angeliki ; Ködmön, Csaba ; Nahapetyan, Karen ; Kraus, Annette ; Alm, Erik ; Adlhoch, Cornelia ; Mooks, Piers ; Dave, Nishi ; Carvalho, Carlos ; Meslé, Margaux Mi ; Daniels, Rodney ; Pebody, Richard</creator><creatorcontrib>Melidou, Angeliki ; Ködmön, Csaba ; Nahapetyan, Karen ; Kraus, Annette ; Alm, Erik ; Adlhoch, Cornelia ; Mooks, Piers ; Dave, Nishi ; Carvalho, Carlos ; Meslé, Margaux Mi ; Daniels, Rodney ; Pebody, Richard ; Members of the WHO European Region influenza surveillance network that contributed virus characterisation data ; Members of the WHO European Region influenza surveillance network</creatorcontrib><description>In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections were confirmed. Substantial proportions of characterised circulating virus subtypes or lineages differed antigenically from their respective northern hemisphere vaccine components. Appropriate levels of influenza virus characterisations should be maintained until the season end and in future seasons, when surveillance is adapted to integrate SARS-CoV-2.</description><identifier>ISSN: 1560-7917</identifier><identifier>ISSN: 1025-496X</identifier><identifier>EISSN: 1560-7917</identifier><identifier>DOI: 10.2807/1560-7917.ES.2022.27.15.2200255</identifier><identifier>PMID: 35426364</identifier><language>eng</language><publisher>Sweden: Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</publisher><subject>COVID-19 ; Health surveillance ; Humans ; Influenza ; Influenza A Virus, H3N2 Subtype - genetics ; Influenza B virus - genetics ; Influenza Vaccines ; Influenza, Human - epidemiology ; Influenza, Human - prevention & control ; Intervention ; Rapid Communication ; SARS-CoV-2 ; Seasons ; Severe acute respiratory syndrome coronavirus 2 ; World Health Organization</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-04, Vol.27 (15), p.1</ispartof><rights>Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) Apr 14, 2022</rights><rights>This article is copyright of the authors or their affiliated institutions, 2022. 2022 The authors or their affiliated institutions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3845-8f16b8b390a51da31d74ace0fe26990aa155eae8fb0f19cffc4f12a22af8644e3</citedby><cites>FETCH-LOGICAL-c3845-8f16b8b390a51da31d74ace0fe26990aa155eae8fb0f19cffc4f12a22af8644e3</cites><orcidid>0000-0002-9069-2885 ; 0000-0002-8755-5193 ; 0000-0001-8040-6753 ; 0000-0002-8842-0469 ; 0000-0002-8735-4674</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012087/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012087/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35426364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melidou, Angeliki</creatorcontrib><creatorcontrib>Ködmön, Csaba</creatorcontrib><creatorcontrib>Nahapetyan, Karen</creatorcontrib><creatorcontrib>Kraus, Annette</creatorcontrib><creatorcontrib>Alm, Erik</creatorcontrib><creatorcontrib>Adlhoch, Cornelia</creatorcontrib><creatorcontrib>Mooks, Piers</creatorcontrib><creatorcontrib>Dave, Nishi</creatorcontrib><creatorcontrib>Carvalho, Carlos</creatorcontrib><creatorcontrib>Meslé, Margaux Mi</creatorcontrib><creatorcontrib>Daniels, Rodney</creatorcontrib><creatorcontrib>Pebody, Richard</creatorcontrib><creatorcontrib>Members of the WHO European Region influenza surveillance network that contributed virus characterisation data</creatorcontrib><creatorcontrib>Members of the WHO European Region influenza surveillance network</creatorcontrib><title>Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><addtitle>Euro Surveill</addtitle><description>In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections were confirmed. Substantial proportions of characterised circulating virus subtypes or lineages differed antigenically from their respective northern hemisphere vaccine components. Appropriate levels of influenza virus characterisations should be maintained until the season end and in future seasons, when surveillance is adapted to integrate SARS-CoV-2.</description><subject>COVID-19</subject><subject>Health surveillance</subject><subject>Humans</subject><subject>Influenza</subject><subject>Influenza A Virus, H3N2 Subtype - genetics</subject><subject>Influenza B virus - genetics</subject><subject>Influenza Vaccines</subject><subject>Influenza, Human - epidemiology</subject><subject>Influenza, Human - prevention & control</subject><subject>Intervention</subject><subject>Rapid Communication</subject><subject>SARS-CoV-2</subject><subject>Seasons</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>World Health Organization</subject><issn>1560-7917</issn><issn>1025-496X</issn><issn>1560-7917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkVFL3TAUx8vYmM7tK4zAHubAW5OTJm1fNuRy5xVEYW7sMZy2J1ppk2vSOtynX4vXi_MlCSe__DknvyT5LHgKBc-PhdJ8kZciT1dXKXCAFPJUqBSAc1DqVbK_I14_O-8l72K85TyTvIS3yZ5UGWips_2kP3O2G8n9RRZoGIOL7E873DBkkTB6xxrftw4Halj1wOoOG2JymQKKalpSYCeHa3kBX9h9G8ZI8Yj9Xl-y1Rj8htCxH3TdenfEplbFMcD75I3FLtKH7X6Q_Pq--rlcL84vT8-WJ-eLWhaZWhRW6KqoZMlRiQalaPIMa-KWQJdTEYVShFTYiltR1tbWmRWAAGgLnWUkD5Kvj7mbseqpqckNATuzCW2P4cF4bM3_N669Mdf-3pRcAC_yKeBwGxD83UhxMH0ba-o6dOTHaEAroUupuZzQTy_QWz_94zTeTElVgNLFRH17pOrgYwxkd80Ibma1ZpZlZllmdWVmtQbmotmqnRI-Pp9p9_7JpfwHBCmdmQ</recordid><startdate>20220414</startdate><enddate>20220414</enddate><creator>Melidou, Angeliki</creator><creator>Ködmön, Csaba</creator><creator>Nahapetyan, Karen</creator><creator>Kraus, Annette</creator><creator>Alm, Erik</creator><creator>Adlhoch, Cornelia</creator><creator>Mooks, Piers</creator><creator>Dave, Nishi</creator><creator>Carvalho, Carlos</creator><creator>Meslé, Margaux Mi</creator><creator>Daniels, Rodney</creator><creator>Pebody, Richard</creator><general>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</general><general>European Centre for Disease Prevention and Control (ECDC)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9069-2885</orcidid><orcidid>https://orcid.org/0000-0002-8755-5193</orcidid><orcidid>https://orcid.org/0000-0001-8040-6753</orcidid><orcidid>https://orcid.org/0000-0002-8842-0469</orcidid><orcidid>https://orcid.org/0000-0002-8735-4674</orcidid></search><sort><creationdate>20220414</creationdate><title>Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22</title><author>Melidou, Angeliki ; Ködmön, Csaba ; Nahapetyan, Karen ; Kraus, Annette ; Alm, Erik ; Adlhoch, Cornelia ; Mooks, Piers ; Dave, Nishi ; Carvalho, Carlos ; Meslé, Margaux Mi ; Daniels, Rodney ; Pebody, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3845-8f16b8b390a51da31d74ace0fe26990aa155eae8fb0f19cffc4f12a22af8644e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>COVID-19</topic><topic>Health surveillance</topic><topic>Humans</topic><topic>Influenza</topic><topic>Influenza A Virus, H3N2 Subtype - genetics</topic><topic>Influenza B virus - genetics</topic><topic>Influenza Vaccines</topic><topic>Influenza, Human - epidemiology</topic><topic>Influenza, Human - prevention & control</topic><topic>Intervention</topic><topic>Rapid Communication</topic><topic>SARS-CoV-2</topic><topic>Seasons</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melidou, Angeliki</creatorcontrib><creatorcontrib>Ködmön, Csaba</creatorcontrib><creatorcontrib>Nahapetyan, Karen</creatorcontrib><creatorcontrib>Kraus, Annette</creatorcontrib><creatorcontrib>Alm, Erik</creatorcontrib><creatorcontrib>Adlhoch, Cornelia</creatorcontrib><creatorcontrib>Mooks, Piers</creatorcontrib><creatorcontrib>Dave, Nishi</creatorcontrib><creatorcontrib>Carvalho, Carlos</creatorcontrib><creatorcontrib>Meslé, Margaux Mi</creatorcontrib><creatorcontrib>Daniels, Rodney</creatorcontrib><creatorcontrib>Pebody, Richard</creatorcontrib><creatorcontrib>Members of the WHO European Region influenza surveillance network that contributed virus characterisation data</creatorcontrib><creatorcontrib>Members of the WHO European Region influenza surveillance network</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melidou, Angeliki</au><au>Ködmön, Csaba</au><au>Nahapetyan, Karen</au><au>Kraus, Annette</au><au>Alm, Erik</au><au>Adlhoch, Cornelia</au><au>Mooks, Piers</au><au>Dave, Nishi</au><au>Carvalho, Carlos</au><au>Meslé, Margaux Mi</au><au>Daniels, Rodney</au><au>Pebody, Richard</au><aucorp>Members of the WHO European Region influenza surveillance network that contributed virus characterisation data</aucorp><aucorp>Members of the WHO European Region influenza surveillance network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><addtitle>Euro Surveill</addtitle><date>2022-04-14</date><risdate>2022</risdate><volume>27</volume><issue>15</issue><spage>1</spage><pages>1-</pages><issn>1560-7917</issn><issn>1025-496X</issn><eissn>1560-7917</eissn><abstract>In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections were confirmed. Substantial proportions of characterised circulating virus subtypes or lineages differed antigenically from their respective northern hemisphere vaccine components. Appropriate levels of influenza virus characterisations should be maintained until the season end and in future seasons, when surveillance is adapted to integrate SARS-CoV-2.</abstract><cop>Sweden</cop><pub>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</pub><pmid>35426364</pmid><doi>10.2807/1560-7917.ES.2022.27.15.2200255</doi><orcidid>https://orcid.org/0000-0002-9069-2885</orcidid><orcidid>https://orcid.org/0000-0002-8755-5193</orcidid><orcidid>https://orcid.org/0000-0001-8040-6753</orcidid><orcidid>https://orcid.org/0000-0002-8842-0469</orcidid><orcidid>https://orcid.org/0000-0002-8735-4674</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1560-7917 |
| ispartof | Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-04, Vol.27 (15), p.1 |
| issn | 1560-7917 1025-496X 1560-7917 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9012087 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | COVID-19 Health surveillance Humans Influenza Influenza A Virus, H3N2 Subtype - genetics Influenza B virus - genetics Influenza Vaccines Influenza, Human - epidemiology Influenza, Human - prevention & control Intervention Rapid Communication SARS-CoV-2 Seasons Severe acute respiratory syndrome coronavirus 2 World Health Organization |
| title | Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A22%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influenza%20returns%20with%20a%20season%20dominated%20by%20clade%203C.2a1b.2a.2%20A(H3N2)%20viruses,%20WHO%20European%20Region,%202021/22&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Melidou,%20Angeliki&rft.aucorp=Members%20of%20the%20WHO%20European%20Region%20influenza%20surveillance%20network%20that%20contributed%20virus%20characterisation%20data&rft.date=2022-04-14&rft.volume=27&rft.issue=15&rft.spage=1&rft.pages=1-&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/1560-7917.ES.2022.27.15.2200255&rft_dat=%3Cproquest_pubme%3E2651693603%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2653582568&rft_id=info:pmid/35426364&rfr_iscdi=true |